Biotech investors are grappling with fresh uncertainty following the abrupt resignation of Dr. Peter Marks, a key figure in the US Food and Drug Administration. Marks, who was instrumental in Operation Warp Speed and known for championing fast-tracked drug approvals, announced his departure on Friday, citing fundamental disagreements with Health…
Rocket Companies (NYSE: RKT) has announced the acquisition of Mr. Cooper in an all-stock transaction valued at $9.4 billion.…
Newsmax, the conservative cable news network, made its public debut on the New York Stock Exchange on Monday, defying…
US stocks are ending March with a decline they haven’t seen in a single month since September of 2022…
Celsius Holdings Inc (NASDAQ: CELH) rallied as much as 10% on Monday after a Truist analyst said the company’s…
Crypto hacks surged to record levels in the first quarter of 2025, with losses surpassing $1.6 billion, according to…
The island nation of Vanuatu has passed regulations for the cryptocurrency industry in a bid to attract compliant firms…
As the world braces for April 2, all eyes are on the United States, where President Donald Trump is…
Casinos have long been a significant part of Canada’s entertainment and economic landscape, evolving from humble brick-and-mortar establishments to…